Clinical outcome and safety of periodic infliximab therapy in children and adolescents with Crohn's disease
- PMID: 15319637
- DOI: 10.1097/00005176-200409000-00018
Clinical outcome and safety of periodic infliximab therapy in children and adolescents with Crohn's disease
Comment on
-
A prospective study of the efficacy and tolerance of a chimeric antibody to tumor necrosis factors (remicade) in severe pediatric crohn disease.J Pediatr Gastroenterol Nutr. 2003 May;36(5):632-6. doi: 10.1097/00005176-200305000-00007. J Pediatr Gastroenterol Nutr. 2003. PMID: 12717087
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
